HGF's Role in Reducing Invasiveness of Breast Cancer Cells
Author Information
Author(s): Ridolfi E, Matteucci E, Maroni P, Desiderio M A
Primary Institution: Institute of General Pathology, University of Milan
Hypothesis
How does HGF affect the invasiveness of aggressive breast carcinoma cells and the role of HDACs in this process?
Conclusion
HGF reduces the invasiveness of MDA-MB231 breast cancer cells by decreasing CXCR4 levels and function, with HDACs playing a regulatory role.
Supporting Evidence
- HGF treatment reduced spontaneous migration and specific chemoinvasion towards CXCL12 in MDA-MB231 cells.
- Blockade of HDACs hindered the HGF-dependent reductions of CXCR4 transactivation and invasiveness.
- HGF reduced motility and CXCR4 functionality only in MDA-MB231 cells, not in low-invasive MCF-7 cells.
Takeaway
HGF helps some aggressive breast cancer cells move less and be less invasive, and blocking certain proteins can change this effect.
Methodology
The study involved treating MDA-MB231 breast cancer cells with HGF and HDAC inhibitors, then assessing changes in cell migration and CXCR4 expression.
Potential Biases
Potential bias in interpreting results due to the focus on specific signaling pathways.
Limitations
The study primarily focused on one cell line and may not fully represent all breast cancer types.
Participant Demographics
The study used MDA-MB231 and MCF-7 breast cancer cell lines.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website